Partial List of Venture Capitalists
THANK YOU FOR YOUR SUPPORT OF BERKELEY ENTREPRENEURS!
- • 3i
- • 5AM Ventures
- • Abingworth Management
- • Activate Capital
- • Acumen Foundation
- • Adams Street Partners
- • Advanced Technology Ventures
- • Ajax Investment Strategies
- • Allen & Company
- • Alta Partners
- • AME Cloud Ventures
- • Amzak Health
- • Apax Partners
- • Applied Genomic Technology Capital (AGTC) Funds
- • Archangel BioVentures
- • Arch Venture Partners
- • Ardesta
- • Atlas Venture
- • Avery Dennison
- • Beagle Ltd.
- • Berkeley Catalyst Fund
- • Bill and Melinda Gates Foundation
- • Biomedical Partners
- • Biotechnology Value Fund
- • BioVeda Capital
- • Casdin Capital
- • Chiesi Ventures Fund
- • Claremont Creek Ventures
- • CMEA Ventures
- • Convexa
- • Credit Suisse First Boston
- • Crocker Capital
- • Cross Creek Advisors
- • CSFB Private Equity
- • DAG Ventures
- • Delphi Ventures
- • De Novo Ventures
- • Deutsche Telekom Strategic Investments
- • DFJ - Draper Fisher Jurvetson
- • Digital Bandwidth
- • Domain Associates
- • Dorm Room Fund
- • Dow Chemical Company
- • Dupont iTechnologies
- • EcoR1 Capital
- • Engie
- • E.M. Warburg, Pincus & Co.
- • Emigrant Capital
- • Equitek Capital
- • Essex Woodlands
- • Fidelity Management and Research Company
- • Fifty Years
- • First Analysis
- • Fisk Ventures
- • Flagship Pioneering
- • Foresite Capital
- • Forward Ventures
- • Frazier Healthcare Ventures
- • Gabriel Venture Partners
- • Gemalto
- • General Catalyst Partners
- • Globespan Capital Partners
- • Goldman, Sachs & Co.
- • Greenspring Associates
- • GV
- • Halo Fund
- • HBM Bioventures (formerly Roche Holding AG)
- • HNW Capital
- • Horizons Ventures
- • Humboldt Fund
- • Hummer Winblad Venture Partners
- • Icon Ventures
- • In-Q-Tel
- • Intel Capital
- • International Biotechnology Trust
- • International BM Biomedicine / Global Biomedical Partners
- • Janus Capital Management
- • Jafco Ventures
- • Juniper Networks
- • Khosla Ventures
- • Kleiner Perkins Caulfield & Byers
- • Kodiak Venture Partners
- • Life Science Angels
- • Lightspeed Venture Partners
- • Lombard Odier & Cie
- • Longevity Vision Fund
- • Lumira Capital
- • Lux Capital
- • M12
- • Macquarie Capiital
- • Matrix Partners
- • Mayfield Fund
- • MDS Capital Corp
- • Mirae Asset Financial Group
- • Mission Bay Capital
- • Mission BioCapital
- • Mohr Davidow Ventures
- • Morningside Ventures
- • Mubadala Capital
- • New Enterprise Associates
- • New Medical Technologies
- • NGEN Partners
- • Norwest Venture Partners
- • Noventi
- • Oak Investment Partners
- • Octagon Capital Group
- • OrbiMed Advisors
- • Osage University Partners
- • Pappas Capital
- • Partech Ventures
- • Pfizer Ventures
- • Philips Electronics
- • Phoenix Venture Partners
- • Physic Ventures
- • Pivotal Ventures
- • Polaris Partners
- • Prolog Ventures
- • Quad Investment Management
- • Qualcomm Ventures
- • Quan Ventures
- • QuestMark Partners
- • Qventures
- • Rock Health
- • RD Fund
- • Rho Management
- • Rona Holdings
- • Samsung Ventures
- • Scale Venture Partners
- • Sectoral Asset Management
- • Sequoia Ventures
- • Sevin Rosen Funds
- • SG Cowen
- • Sierra Ventures
- • Skyline Ventures
- • StartX
- • Strategic Partners
- • Streamlined Ventures
- • T Venture
- • Tallwood Venture Capital
- • The Angels' Forum
- • The Column Group
- • Third Rock Ventures
- • Thomas, McNerny & Partners
- • Toray International
- • TPG Growth
- • Tuatara Capital, L.P.
- • UPM-Kymmene
- • Vantage Point Capital Partners
- • Venrock Associates
- • Versant Ventures
- • Viking Global Investors
- • Vision Ridge Capital
- • Vista Ventures
- • Walden Riverwood Ventures
- • Western Technology Investment Inc. (WTI)
- • Wilson Sonsini Goodrich & Rosati
- • X/Seed Capital Management
© 2002-2016 Regents of the University of California. All Rights Reserved.